List of works by Carla De Giovanni

17β-estradiol, 5α-Dihydrotestosterone, Progesterone and Cortisol Receptors in Normal and Neoplastic Human Endometrium ⬇️

scientific article published on April 30, 1979

2011: the immune hallmarks of cancer

scientific article published on 26 January 2011

A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function.

scientific article

Antimetastatic Activity of a Preventive Cancer Vaccine

scientific article (publication date: 15 November 2007)

Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity

scientific article published on March 2004

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R.

scientific article published on 11 April 2019

Cancer immunoprevention

scientific article

Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment

scientific article published on 24 October 2013

Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role

scientific article published on 24 January 2006

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression

scientific article published in 2021

Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells.

scientific article published on September 2002

Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma

scientific article published on 29 May 1997

HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.

scientific article

High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.

scientific article published on 22 December 2009

Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.

scientific article

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis

scientific article published on 07 February 2019

Immunological prevention of a multigene cancer syndrome

scientific article

Immunoprevention and immunotherapy of mammary carcinoma

scientific article published in September 2010

Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine

scientific article published in June 2004

Immunoprevention of colorectal cancer: a future possibility?

scientific article

In silico modeling and in vivo efficacy of cancer-preventive vaccinations.

scientific article

Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells

scientific article published on March 2004

Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells

scholarly article

Inhibition of prostate carcinogenesis by combined active immunoprophylaxis

scientific article published on July 2007

Molecular and cellular biology of rhabdomyosarcoma.

scientific article

Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor

scientific article (publication date: 2012)

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

scientific article published on 11 June 2018

Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4.

scientific article published in April 2009

Preclinical HER-2 Vaccines: From Rodent to Human HER-2

scientific article published on 10 June 2013

Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.

scientific article

Preclinical vaccines against mammary carcinoma

scientific article published on December 2013

Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.

scientific article published in June 2003

Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system.

scientific article published on November 2010

Rethinking herpes simplex virus: the way to oncolytic agents

scientific article published on 27 May 2011

Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.

scientific article published on 31 January 2009

The molecular basis of herpesviruses as oncolytic agents

scientific article published on July 2012

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

scientific article published on 23 January 2014

Vaccines and other immunological approaches for cancer immunoprevention

scientific article published on December 2011

Paulina is supported by:

About Paulina

Help